RAPT Therapeutics, Inc. - RAPT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 5.9% | 1,637,165 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 5.9% | 1,637,165 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.4% | 110,448 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.4% | 110,448 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Kroin | 0.4% | 110,448 | View |
| Feb 09, 2026 | SCHEDULE 13G | Glazer Capital, LLC | 5.36% | 1,486,094 | View |
| Feb 09, 2026 | SCHEDULE 13G | Paul J. Glazer | 5.36% | 1,486,094 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF I GP LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF II GP LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF INC/IL | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | LAMPERT MARK N | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 3.77% | 623,282 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Wilmot B. Harkey | 3.77% | 623,282 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Daniel Mack | 3.77% | 623,282 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ORBIMED ADVISORS LLC | 6.6% | 1,086,618 | View |
| Oct 30, 2025 | SCHEDULE 13G/A | The Vanguard Group | 4.2% | 696,188 | View |
| Oct 29, 2025 | SCHEDULE 13G | ForGrowth III PA B.V. | 7.4% | 1,833,333 | View |
| Oct 29, 2025 | SCHEDULE 13G | Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.4% | 1,833,333 | View |
| Oct 29, 2025 | SCHEDULE 13G | Forbion Growth III Management B.V. | 7.4% | 1,833,333 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.